Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility Study of Using MR-guided High Intensity Focused Ultrasound (HIFU) for the Ablation of Relapsed or Refractory Pediatric Solid Tumors

NCT02076906 is registered in ClinicalTrials.gov with AeRang Kim as lead sponsor.

NCT NCT02076906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02076906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility Study of Using MR-guided High Intensity Focused Ultrasound (HIFU) for the Ablation of Relapsed or Refractory Pediatric Solid Tumors
Lead sponsor
AeRang Kim
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2014
Completion date
November 24, 2024
Enrollment
7 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

desmoid tumor, ewing sarcoma, germ cell tumor, hepatic tumor, neuroblastoma, osteosarcoma, refractory pediatric solid tumors, relapsed pediatric solid tumors, rhabdomyosarcoma, wilms tumor